The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · Insurance & coverage · continued

Documentation that materially improves an appeal's chances posts 91–99

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

SG
s.grahameTL25 Dec 2025#91
AK
ar.kravchenkoTL26 Dec 2025#92
footnote_entry, post #55: Post #52 answers the question as asked. The question underneath it is different. The most useful reply I ever got about documentation was a request to state my units. It sounds like pedantry and it has saved me twice. Go to post

Nobody has said the unglamorous part of documentation yet, so: most of the variation is explained by things that are boring to write about and easy to check.

0 likes in reply to #55 8mo
CI
citation_indexTL2Member7 Dec 2025 · edited#93

Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose.

I would call that likely rather than established.

0 likes 8mo
ER
e.roosTL27 Dec 2025#94

Small correction to my own earlier position on documentation. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.

4 likes 8mo
B
BirkelandTL3Regular8 Dec 2025#95

Thank you for the correction. I would rather find out here than later.

12 likes 8mo
AK
a.kravchenkoTL29 Dec 2025#96
osmolal_table, post #67: Thank you — that answers what I came here to find out. Go to post

Where a criterion requires documented prior attempts, the documentation has to exist in the record rather than in your memory of it.

That is all the detail I have. Someone else will have more.

25 likes in reply to #67 8mo
BJ
b.jankowiakTL3Regular10 Dec 2025#97
so.cardoso, post #3: I had written a reply contradicting the opening post and deleted it. Here is what survived. A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is a conversation with somebody who can decide. Go to post

Before the thread moves on from documentation — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred.

0 likes in reply to #3 8mo
VR
v.rautioTL210 Dec 2025#98

Where I part company with post #94, and it is a narrow parting.

Adding the boring version of documentation, because the interesting version keeps getting posted and the boring one is usually right.

Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.

1 like 8mo
YM
y.mensahTL3Wiki editor11 Dec 2025#99

Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and responding point-by-point to it works better than general appeals.

Take it as a starting point and not as a specification.

7 likes 8mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Coverage for the indication versus for the drug — a second dataset
On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and…
TSEFKJHV+46 50 41k 16mo
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. The question about peer-to-peer review that I actually want answered is the second…
NNECPB 2 1.2k 1d
Appeal templates and why they are deliberately unemotional
Posting this under the heading it deserves: Appeal templates and why they are deliberately unemotional Everything below is what sits behind that. A narrow question about appeal templates, deliberately narrow,…
DOTNCSBAE+25 29 764 7mo
An appeal that succeeded, with the letter structure — the long version
An appeal that succeeded, with the letter structure — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about appeal, deliberately narrow, because the…
GTAKJNBPMS+113 136 32k 1mo
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking about Reading a denial letter on behalf of…
HAITBBPMN+125 138 9.4k 10mo

Related topics — sharing the tags insurance, appeals, formulary

TopicParticipantsRepliesViewsActivity
About the Insurance & coverage category
Prior authorisation, appeals, denial letters, and documentation that helps. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
OBHSDSFWDF+2 6 3.2k 3mo
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
GPMYASKHFA+46 50 7.9k 5mo
Pen wastage and its effect on real cost
Pen wastage and its effect on real cost Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers on pen wastage, because they…
WVGPFYWMG+29 33 19k 21mo
Coming back to: Cost per delivered dose, which is the number that matters
On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
ILTVSDSCHD+6 10 2.5k 19mo
Asking about a compound your prescriber has not heard of — one year on
On the subject in the title: Asking about a compound your prescriber has not heard of — one year on Working notes rather than a conclusion. A question about how to describe something to a clinician rather…
ESMHKDOBSG+11 15 3.7k 19mo